Table 1.
Characteristics of the study cohort (n = 576)
| Characteristics | Data |
|---|---|
| Age at baseline, years | 53.93 ± 9.20 |
| Sex, male, % | 456 (79.17%) |
| Duration between LT and SRL initiation, months | 15.70 ± 33.5 |
| eGFR at baseline, ml/min/1.73 m2 | 78.60 ± 42.94 |
| SCr at baseline, mg/dL | 1.16 ± 0.72 |
| Positive proteinuria at baseline (n = 535), n (%) | 75 (14.02%) |
| Indications for liver transplantation, n (%) a | |
| Decompensated liver cirrhosis | |
| Hepatitis B | 317 (55.03%) |
| Hepatitis C | 162 (28.13%) |
| Alcoholic | 87 (15.10%) |
| HCC | 318 (55.21%) |
| Acute liver failure | 34 (5.9%) |
| Baseline comorbidities, n (%) | |
| Congestive heart failure | 3 (0.52%) |
| Diabetes mellitus | 144 (25%) |
| Celebrovascular disease | 5 (0.87%) |
| Chronic pulmonary disease | 26 (4.52%) |
| Renal disease | 21 (3.65%) |
| CNI use at baseline | 520 (90.28%) |
| Plasma trough level of SRL, ng/mL | |
| <3 months, | 6.19 ± 3.52 |
| 3-6 months | 6.26 ± 2.96 |
| 6-12 months | 6.19 ± 2.88 |
| Duration of follow-up, day, (n = 574) | 1075 ± 871.2 |
Data presents as mean ± SD for continuous data, and n (%) for categorical data
aNot excluding events